Sentinel lymph node biopsy in gastric cancer

Hiroya Takeuchi, Yuukou Kitagawa

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Clinical application of sentinel lymph node (SLN) mapping in patients with early-stage gastric cancer has been a controversial issue for years. However, a recent meta-analysis and a prospective multicenter trial of SLN mapping for early-stage gastric cancer have shown acceptable SLN detection rates and accuracy of determination of lymph node status. A dual-tracer method that uses radioactive colloids and blue dyes is currently considered the most reliable method for the stable detection of SLNs in patients with early-stage gastric cancer. However, the new technologies such as indocyanine green infrared or fluorescence imaging might revolutionize the SLN mapping procedures in gastric cancer. For early-stage gastric cancer, the establishment of individualized, minimally invasive treatments based on SLN concept may retain the patients' quality of life.

Original languageEnglish
Pages (from-to)21-24
Number of pages4
JournalCancer Journal (United States)
Volume21
Issue number1
DOIs
Publication statusPublished - 2015 Feb 6

Fingerprint

Sentinel Lymph Node Biopsy
Stomach Neoplasms
Indocyanine Green
Optical Imaging
Colloids
Multicenter Studies
Meta-Analysis
Coloring Agents
Lymph Nodes
Quality of Life
Sentinel Lymph Node
Technology

Keywords

  • gastric cancer
  • laparoscopic,indocyanine green
  • Sentinel lymph nodes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Sentinel lymph node biopsy in gastric cancer. / Takeuchi, Hiroya; Kitagawa, Yuukou.

In: Cancer Journal (United States), Vol. 21, No. 1, 06.02.2015, p. 21-24.

Research output: Contribution to journalArticle

@article{e8aaff272f4e49868cd998cc0bc3fde8,
title = "Sentinel lymph node biopsy in gastric cancer",
abstract = "Clinical application of sentinel lymph node (SLN) mapping in patients with early-stage gastric cancer has been a controversial issue for years. However, a recent meta-analysis and a prospective multicenter trial of SLN mapping for early-stage gastric cancer have shown acceptable SLN detection rates and accuracy of determination of lymph node status. A dual-tracer method that uses radioactive colloids and blue dyes is currently considered the most reliable method for the stable detection of SLNs in patients with early-stage gastric cancer. However, the new technologies such as indocyanine green infrared or fluorescence imaging might revolutionize the SLN mapping procedures in gastric cancer. For early-stage gastric cancer, the establishment of individualized, minimally invasive treatments based on SLN concept may retain the patients' quality of life.",
keywords = "gastric cancer, laparoscopic,indocyanine green, Sentinel lymph nodes",
author = "Hiroya Takeuchi and Yuukou Kitagawa",
year = "2015",
month = "2",
day = "6",
doi = "10.1097/PPO.0000000000000088",
language = "English",
volume = "21",
pages = "21--24",
journal = "Cancer Journal from Scientific American",
issn = "1528-9117",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Sentinel lymph node biopsy in gastric cancer

AU - Takeuchi, Hiroya

AU - Kitagawa, Yuukou

PY - 2015/2/6

Y1 - 2015/2/6

N2 - Clinical application of sentinel lymph node (SLN) mapping in patients with early-stage gastric cancer has been a controversial issue for years. However, a recent meta-analysis and a prospective multicenter trial of SLN mapping for early-stage gastric cancer have shown acceptable SLN detection rates and accuracy of determination of lymph node status. A dual-tracer method that uses radioactive colloids and blue dyes is currently considered the most reliable method for the stable detection of SLNs in patients with early-stage gastric cancer. However, the new technologies such as indocyanine green infrared or fluorescence imaging might revolutionize the SLN mapping procedures in gastric cancer. For early-stage gastric cancer, the establishment of individualized, minimally invasive treatments based on SLN concept may retain the patients' quality of life.

AB - Clinical application of sentinel lymph node (SLN) mapping in patients with early-stage gastric cancer has been a controversial issue for years. However, a recent meta-analysis and a prospective multicenter trial of SLN mapping for early-stage gastric cancer have shown acceptable SLN detection rates and accuracy of determination of lymph node status. A dual-tracer method that uses radioactive colloids and blue dyes is currently considered the most reliable method for the stable detection of SLNs in patients with early-stage gastric cancer. However, the new technologies such as indocyanine green infrared or fluorescence imaging might revolutionize the SLN mapping procedures in gastric cancer. For early-stage gastric cancer, the establishment of individualized, minimally invasive treatments based on SLN concept may retain the patients' quality of life.

KW - gastric cancer

KW - laparoscopic,indocyanine green

KW - Sentinel lymph nodes

UR - http://www.scopus.com/inward/record.url?scp=84922318816&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922318816&partnerID=8YFLogxK

U2 - 10.1097/PPO.0000000000000088

DO - 10.1097/PPO.0000000000000088

M3 - Article

C2 - 25611776

AN - SCOPUS:84922318816

VL - 21

SP - 21

EP - 24

JO - Cancer Journal from Scientific American

JF - Cancer Journal from Scientific American

SN - 1528-9117

IS - 1

ER -